Entry into the organ transplantation and organ preservation device business through the acquisition of OrganOx

An individual M&A theme involving the acquisition of OrganOx Limited as a wholly owned subsidiary, entry into the organ transplantation sector through the incorporation of its organ preservation device business using normothermic machine perfusion (NMP) technology, and expansion globally.